Product name MyGluco®
Brand BewellConnect®
Model BW-GL1
Medical device CE 0123
Classification In Vitro Diagnostic (IVD) Medical Device)
Measurement zone Drop of capillary blood
Precision ±15mg/dL si <100mg/dL; ±15% si ≥100mg/dL
Measurement Range 20~600mg/dL (1,1~33,3 mmol/L)
Measurement Units mg/dL ou mmol/L
Operating Condition 10-40°C / 50-104°F, below 85% R.H. (non-condensing)
Memory 450 measures (with date and time)
LED screen 2*1,25*1,1mm / 0,08*0,05*0,04 in
Auto switch-off 3 minutes
Bluetooth technology 4.0
Compatibility iOS 8 (iPhone 4S and more), Androïd 4.3
Bluetooth range 10m / 393,70 in
Frequency 4 MHz
Product dimension 95,4*50*22,5mm / 3,7*2*0,9 in
Weight 83g /0,19 lb
Source 2 x 1,5V AAA alkalines batteries
Uptake ≤50mW
DC voltage 3V
Response time 6 seconds
Accessories provided 1 lancing device, 10 test strips, 10 lancets, 1 instruction manual, 1
quickstep, 2 x 1.5V AAA batteries, 1 follow-up logbook, 1 warranty card,
1 lancing device manual and 1 carrying case
Warranty 2 years (without accessories)


Connected blood sugar meter



Connected blood sugar meter

MyGluco® is a connected blood sugar meter. In vitro diagnostic medical device, it can measure the concentration of glucose in the blood and control glycemic targets. Convenient and adapted for patient use, it easily integrates with remote monitoring programs.


In vitro medical device

In vitro medical device

Display of the blood glucose result on the screen

Measurement done with a small drop of blood: 0.7 microliter

Estimated levels of glycated hemoglobin * (from average blood glucose for the last three months)

AST function (taking a drop of blood elsewhere than on the tip of the finger)

Personalized tracking logbook in app with doses of injected insulins, meals (by time slot), activities performed

Connectivity via Bluetooth Low Energy

* The glycated hemoglobin is estimated from eAG (estimated Average Glucose) on a relation which is: eAG (in mg / dl) = 28.7 X HbA1c – 46.7

Product’s benefits

Illustration des + produits ; MyGluco avec sa bandelette de test est collé à un smartphone montrant l'écran d'un compte utilisateur de l'application MyGluco.
  • Display of the result in 6 seconds
  • Sampling comfort (thanks to the AST function)
  • Suitable for all types of diabetes **: type 1, type 2 and gestational diabetes
  • easy interpretation based on the diagnostic color that fits the defined objective

** Required in insulin-treated type 2 diabetes and variable for non-insulinotrial type 2 diabetics.

Use cases

  • Remote monitoring as part of the return home after a hospitalization (outpatient surgery, intervention, chemotherapy ...)
  • Remote monitoring of chronic patients
  • Equipment of a medical or nursing practice
Illustration des cas d’usages ; les mains d'un utilisateur tenant MyGluco des 2 mains, un smartphone posé sur une table montre l'application MyGluco.

Additional solutions

A telemonitoring and care coordination platform
  • Connecting gateways (smartphone and tablet). MyGluco must be connected via Bluetooth to a gateway that allows patient data to be reassembled in a secure way via Wifi, 2G, 3G, 4G networks to the healthcare professional
  • MyGluco® - can be used with VisioCheck via Bluetooth
  • Secure cloud HDS - storage and interoperability solution for patient data

Interoperable format HL7 FHIR. APIs available on request for third-party server integration

  • BewellXpert® - telemonitoring and care coordination platform

MyGluco® – Ref: BW-GL1. This in vitro diagnostic medical device is a regulated health product that carries the CE – CE0123 mark under the regulations. MedNet GmbH. Read the instructions BW-GL1 (December 2014) carefully

Contact our pro solutions team

You need more information? Our commercial team is at your disposition.